Company | Name | Exchange | Sector | Industry | Return on Invested Capital | Market Cap | P/E Ratio | PEG Ratio | Last Trade Price | Day Change (%) | Fair Value | Fair Value Upside | Fair Value Label | Analyst Price Target | Analyst Target Upside | Overall Health |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Upgrade to Pro+ | Switzerland | Healthcare | Pharmaceuticals | 35.4% | CHF 719.21B | 74.3x | 0.73 | CHF 745 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Upgrade to Pro+ | Switzerland | Industrials | Construction & Engineering | 27.6% | CHF 1.04B | 19.3x | 2.54 | CHF 98.40 | 0.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -0.4% Downside | Upgrade to Pro+ | |
Upgrade to Pro+ | Switzerland | Financial | Investment Banking & Investment Services | 27.4% | CHF 36.19B | 37.5x | -2.62 | CHF 1,386 | -2.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -0.6% Downside | Upgrade to Pro+ | |
Upgrade to Pro+ | Switzerland | Industrials | Machinery, Tools, Heavy Vehicles, Trains & Ships | 27% | CHF 8.33B | 55.8x | 3.12 | CHF 677.50 | 0.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -9.1% Downside | Upgrade to Pro+ | |
Upgrade to Pro+ | Switzerland | Financial | Investment Banking & Investment Services | 26.9% | CHF 6.09B | 23.8x | 0.64 | CHF 409.60 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -17% Downside | Upgrade to Pro+ | |
Upgrade to Pro+ | Switzerland | Consumer Cyclicals | Homebuilding & Construction Supplies | 25.5% | CHF 16.77B | 28x | -2.7 | CHF 508 | -1.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -0.6% Downside | Upgrade to Pro+ | |
Upgrade to Pro+ | Switzerland | Consumer Cyclicals | Homebuilding & Construction Supplies | 25.5% | CHF 16.77B | 28x | -2.7 | CHF 510.60 | -1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Upgrade to Pro+ | Switzerland | Healthcare | Pharmaceuticals | 24.1% | CHF 231.92B | 28x | -1 | CHF 289 | 0.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 1% Upside | Upgrade to Pro+ | |
Upgrade to Pro+ | Switzerland | Healthcare | Pharmaceuticals | 24.1% | CHF 231.92B | 28x | -1 | CHF 308.20 | 0.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -7.2% Downside | Upgrade to Pro+ |